School of Medicine
Showing 1-10 of 23 Results
-
Lia Talozzi
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Talozzi aims to contribute to the definition of quantitative biomarkers for neurological pathologies. She has a physics background, and a master's in applied physics. She graduated with honors from Bologna University, where she pursued her Ph.D. in Biomedical and Neuromotor Sciences. During her doctoral studies, she worked primarily with magnetic resonance imaging, majoring in tractography methods, for which she was awarded a scholarship at the Neuroanatomy and Tractography Laboratory, King's College London. Subsequently, she exploited dimensionality reduction techniques for associating white matter damage with clinical symptoms within the Bordeaux University Disconnectome ERC grant. Currently, she expanded her research horizons to genetic investigations by joining the Greicius Lab. She aims to develop novel strategies for modeling risk scores for Alzheimer's pathology using long read sequencing methodologies.
-
Ryan Taylor, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology.
